TQ10 - Overview: Coenzyme Q10, Total, Plasma

Diagnosis of primary coenzyme Q10 (CoQ10) deficiencies in some patients who are not supplemented with CoQ10 Monitoring patients receiving statin therapy Monitoring CoQ10 status during treatment of various degenerative conditions,...

FCDSU - Overview: Comprehensive Drug Screen, Umbilical Cord Tissue

Comprehensive Drug Screen, Umbilical Cord Tissue

CHLBF - Overview: Cholesterol, Body Fluid

Aiding in the diagnosis of a cholesterol effusion or cholesterol-rich pseudochylous effusion in body fluids Distinguishing between chylous and pseudochylous pleural effusions Distinguishing between malignant and nonmalignant ascites

CARTF - Overview: Carbamazepine Profile, Serum

Monitoring patients exhibiting symptoms of carbamazepine toxicity whose total serum carbamazepine concentration is within the therapeutic range, but who may be producing significant levels of the active metabolite epoxide Free...

CEE52 - Overview: CD52 Cell Expression Evaluation, Varies

Detecting cell-surface antigens on malignant cells that are potential therapeutic antibody targets, specifically CD52 Determining the eligibility of patients for monoclonal antibody therapies Monitoring response to the therapeutic...

IGE - Overview: Immunoglobulin E (IgE), Serum

Evaluating patients with suspected diseases associated with elevations in total immunoglobulin E (IgE), including allergic disease, primary immunodeficiencies, infections, malignancies, or other inflammatory diseases Diagnostic evaluation...

GALP - Overview: Galactose, Quantitative, Plasma

Screening for galactosemia

GDUCR - Overview: Gadolinium/Creatinine Ratio, Random, Urine

Assessing chronic exposure and monitoring effectiveness of dialysis in a random urine collection

GALU - Overview: Galactose, Quantitative, Random, Urine

Screening test for galactosemia using urine specimens

DIS - Overview: Human Leukocyte Antigens (HLA) Class I and II Disease Association Typing, Low Resolution, Blood

Identifying class I and II human leukocyte antigens (HLA) for potential disease associations or markers for drug hypersensitivity